Search alternatives:
points decrease » point decrease (Expand Search), point increase (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 points » 5 points (Expand Search), 5 point (Expand Search), _ points (Expand Search)
Showing 241 - 260 results of 100,719 for search '(( 50 points decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.44s Refine Results
  1. 241
    RTA 408 Increases Expression of Nrf2 Target Genes and Decreases Expression of Inflammatory Mediators in RAW 264.7 Cells.

    RTA 408 Increases Expression of Nrf2 Target Genes and Decreases Expression of Inflammatory Mediators in RAW 264.7 Cells. by Brandon L. Probst (727964)

    Published 2015
    Save to List
    Saved in:
  2. 242
    Whole brain volume change over 5 years using the SIENA pipeline.

    Whole brain volume change over 5 years using the SIENA pipeline. by Renxin Chu (5169857)

    Published 2018
    Save to List
    Saved in:
  3. 243
    Down-regulation of pol III activity in hypoxia is not due to a decrease in the abundance of TFIIIB, TFIIIC or pol III subunits

    Down-regulation of pol III activity in hypoxia is not due to a decrease in the abundance of TFIIIB, TFIIIC or pol III subunits by Isabelle Ernens (13462)

    Published 2011
    Save to List
    Saved in:
  4. 244
    Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells.

    Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)

    Published 2025
    Save to List
    Saved in:
  5. 245
    Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity.

    Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

    Published 2014
    Save to List
    Saved in:
  6. 246
    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
    Save to List
    Saved in:
  7. 247
    Exploration of up- and down-regulated genes at each UV irradiation time-point.

    Exploration of up- and down-regulated genes at each UV irradiation time-point. by Seon-Pil Jin (17364626)

    Published 2023
    Save to List
    Saved in:
  8. 248
    Decreased PGC-1α expression is associated with a hyperglycemia-induced increase in mitochondrial fragmentation and ROS generation.

    Decreased PGC-1α expression is associated with a hyperglycemia-induced increase in mitochondrial fragmentation and ROS generation. by Kaifeng Guo (296791)

    Published 2015
    Save to List
    Saved in:
  9. 249
    Demographics and baseline characteristics of the safety population.

    Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 250
    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model.

    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 251
    Grading of stool consistency and diarrhea severity.

    Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 252
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 253
    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population.

    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 254
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 255
    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population.

    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 256
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 257
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 258
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 259
    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model.

    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 260
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: